Compare UFPT & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UFPT | NVAX |
|---|---|---|
| Founded | 1963 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 1996 | 1996 |
| Metric | UFPT | NVAX |
|---|---|---|
| Price | $255.48 | $8.77 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 9 |
| Target Price | ★ $289.00 | $11.33 |
| AVG Volume (30 Days) | 147.1K | ★ 4.4M |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 15.44 | ★ 309.76 |
| EPS | ★ 2.24 | N/A |
| Revenue | $602,797,000.00 | ★ $1,123,479,000.00 |
| Revenue This Year | $8.12 | N/A |
| Revenue Next Year | $5.72 | N/A |
| P/E Ratio | $112.83 | ★ N/A |
| Revenue Growth | 19.50 | ★ 64.69 |
| 52 Week Low | $173.86 | $6.20 |
| 52 Week High | $274.93 | $11.85 |
| Indicator | UFPT | NVAX |
|---|---|---|
| Relative Strength Index (RSI) | 71.73 | 44.04 |
| Support Level | $205.96 | $7.94 |
| Resistance Level | $270.31 | $9.02 |
| Average True Range (ATR) | 9.57 | 0.60 |
| MACD | 1.89 | -0.09 |
| Stochastic Oscillator | 97.01 | 27.54 |
UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.